Vivos (RDGL) Cash from Financing Activities (2010 - 2025)
Vivos (RDGL) posted Cash from Financing Activities of -$845.0 for Q4 2025, down 100.06% sequentially from $1.5 million in Q1 2025, and down 100.06% YoY from $1.5 million in Q4 2024.
Vivos (RDGL) Cash from Financing Activities (2010 - 2025) Analysis & Trends
Vivos has reported Cash from Financing Activities for 15 years, with the latest figure at -$845.0 in Q4 2025.
- Quarterly Cash from Financing Activities fell 100.06% year-over-year to -$845.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (down 34.6% YoY) and the FY2025 annual result came in at $1.5 million, down 34.6% from the prior year.
- Cash from Financing Activities slipped to -$845.0 in Q4 2025 per RDGL's latest filing, from $1.5 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $1.8 million in Q1 2021 and troughed at -$145000.0 in Q4 2021.
- A 4-year average of $667335.9 and a median of $518580.0 in 2023 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 2420.16% in 2021, down 111.56% in 2021.
- Over 4 years, Cash from Financing Activities stood at -$145000.0 in 2021, then jumped by 457.64% to $518580.0 in 2023, then soared by 182.56% to $1.5 million in 2024, then sank by 100.06% to -$845.0 in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$845.0, $1.5 million, and $1.5 million for Q4 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | -845.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -845.00 |
| Dec 31, 2025 | -845.00 |
| Mar 31, 2025 | 1.51 Mn |
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Jun 30, 2024 | 709,000.00 |
| Jun 30, 2024 | 709,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Dec 31, 2023 | 518,580.00 |
| Dec 31, 2023 | 518,580.00 |
| Sep 30, 2023 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Dec 31, 2021 | -145,000.00 |
| Dec 31, 2021 | -145,000.00 |
| Mar 31, 2021 | 1.81 Mn |
| Mar 31, 2021 | 1.81 Mn |
| Dec 31, 2020 | 1.25 Mn |
| Dec 31, 2020 | 1.25 Mn |